MedPath

comparison the effects of Etomidate and remifentanil on hemodynamic

Phase 3
Recruiting
Conditions
Cataract.
Registration Number
IRCT20220309054238N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients with grade 1 and grade 2 physical status of ASA(American society of Anesthesiologists)
Patients without cardiac disease
Patients without chronic kidney disease
Patients without metabolic disease
Patients without known hypersensitivity reaction to Etomidate and Remifentanil
patients who provide informed consent

Exclusion Criteria

cardiac arrest during surgery or recovery
patients who didn't provide consent

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean Arterial pressure Which is the average arterial pressure throughout one cycle. Timepoint: measuring blood pressure right after induction and in 5,10,15,20 minutes after induction(during surgery). Method of measurement: Measuring blood pressure with vital sign monitoring device during surgery.(Non-invasive blood pressure measuring).;Pulse rate. Timepoint: measuring Pulse rate right after induction and in 5,10,15,20 minutes after induction(during surgery). Method of measurement: Measuring pulse rate with vital sign monitoring device during surgery.(ECG/Resp ).;Respiratory rate. Timepoint: measuring Respiratory rate right after induction and in 5,10,15,20 minutes after induction(during surgery). Method of measurement: Measuring respiratory rate with vital sign monitoring device during surgery.(ECG/Resp ).
Secondary Outcome Measures
NameTimeMethod
Pain score. Timepoint: After Surgery(in recovery room). Method of measurement: Visual Analogue scale.
© Copyright 2025. All Rights Reserved by MedPath